Cinnarizine L tartrate is a pharmaceutical compound used primarily as an anti-vertigo and anti-nausea medication. It is a combination of cinnarizine, an antihistamine, and tartrate, a salt compound. Cinnarizine acts as a calcium channel blocker, preventing the entry of calcium ions into various cells of the body, including those in the inner ear and the brain. By inhibiting calcium influx, it helps to reduce the overstimulation of certain cells responsible for causing dizziness and motion sickness.
Cinnarizine L tartrate is commonly prescribed to treat symptoms associated with Meniere's disease, a condition characterized by recurring episodes of vertigo, hearing loss, and tinnitus. It is also used to alleviate symptoms of motion sickness, including nausea, vomiting, and dizziness, often experienced during traveling or exposure to certain motion activities.
As an antihistamine, cinnarizine L tartrate helps to suppress allergy symptoms by blocking the action of histamine, a chemical substance released during an allergic reaction that causes itching, sneezing, and a runny nose.
Although generally considered safe, cinnarizine L tartrate may cause some side effects. Common side effects may include drowsiness, dry mouth, constipation, and blurred vision. It is important to consult a healthcare professional before taking cinnarizine L tartrate, especially if you have a history of certain medical conditions or are taking other medications, to ensure its safe use and minimize the likelihood of potential drug interactions.
